MARATTO

article · International Journal for Holistic Research

Mitigating Acute Kidney Injury: The Role of Naringenin in Rhabdomyolysis

20241 citationOpen accessSuez University

Abstract

Rhabdomyolysis, which is defined as the breakdown of skeletal muscle, can lead to severe problems such as acute kidney injury (AKI), which represents a serious medical emergency. Naringenin is a bioflavonoid that may be found in citrus fruits. The purpose of this study is to evaluate the preventive benefits of naringenin against glycerol-induced AKI in ants. In this experiment, twenty-four male Wistar rats were randomly assigned to one of three groups: control, glycerol-treated, or naringenin-pretreated. Histopathological investigations and biochemical studies were carried out to evaluate the function of the kidneys and the extent of the damage to the tissues. According to the findings, naringenin was able to dramatically lower kidney damage markers such as renal somatic index, serum creatinine, and blood urea nitrogen levels when compared to the group that was given glycerol. A significant improvement in kidney architecture was observed in the rats who were treated with naringenin, as determined by histological examinations. These findings demonstrate that naringenin has a protective effect against AKI caused by rhabdomyolysis, possibly because of its antioxidant capabilities. This highlights the therapeutic potential of naringenin in the management of kidney-related problems.

Research topics

  • Muscle and Compartmental Disorders
  • Electroconvulsive Therapy Studies
  • Pharmacology and Obesity Treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/ijhr.2024.332558.1033

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.